This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Eastman Chemical (EMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical Gains on Cost Actions & Innovation Amid Demand Woes
by Zacks Equity Research
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
PPG and Shaw Ink Agreement for Resinous Flooring Products
by Zacks Equity Research
Shaw's position as a leading flooring provider with a large client base offers PPG better market access.
DuPont Expands Photoresist Manufacturing Capacity in Japan
by Zacks Equity Research
DD's Sasakami location has been critical to the long-term expansion of its electronic materials portfolio, as it serves clients throughout the Asia-Pacific.
Eastman Chemical's Stock Gains 14% in 3 Months: Here's Why
by Zacks Equity Research
EMN benefits from its innovation-driven growth model and cost-cutting, productivity and price hike actions across its segments.
AdvanSix Stock Dirt Cheap: Should You Buy Now?
by Anindya Barman
With favorable demand and pricing fundamentals, solid financial health and rising earnings estimates, ASIX presents a compelling investment case.
Why Is Kronos Worldwide (KRO) Up 5.6% Since Last Earnings Report?
by Zacks Equity Research
Kronos Worldwide (KRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Onto Eastman Chemical Stock for Now
by Zacks Equity Research
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
Huntsman (HUN) Up 3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Huntsman (HUN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eastman Chemical's (EMN) Shares Gain 14% in 6 Months: Here's Why
by Zacks Equity Research
Better-than-expected earnings performance in the second quarter and upbeat prospects have contributed to the run-up in Eastman's (EMN) shares.
Eastman (EMN) Gains on Cost Cuts & Innovation Amid Demand Woes
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from weak demand in certain markets.
BASF (BASFY) Unveils Fourtiva Catalyst to Boost Butylene Yields
by Zacks Equity Research
The AIM technology of BASF (BASFY) improves FCC catalyst performance by optimizing matrix acidity, activity, pore size distribution and matrix-zeolite interaction, resulting in coke selectivity.
Eastman Chemical (EMN) Q2 Earnings Top Estimates, Sales Miss
by Zacks Equity Research
The sales volume of Eastman Chemical (EMN) in Q2 increases due to the end of customer inventory destocking in most end markets.
Eastman Chemical (EMN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Eastman Chemical (EMN) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eastman Chemical (EMN) Q2 Earnings Top Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 8.04% and 0.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Eastman (EMN) is expected to have benefited from cost-cutting and productivity initiatives as well as its innovation-driven growth strategy amid headwinds from soft demand in certain markets in Q2.
Earnings Preview: Methanex (MEOH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Methanex (MEOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Eastman Chemical (EMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
DuPont (DD), Eastman Chemical (EMN), Avient (AVNT) and Westlake (WLK) are likely to have benefited from cost and pricing actions as well as improved end-market demand on a moderation of de-stocking activities in Q2.
Zacks Industry Outlook Eastman Chemical, Cabot and Kronos Worldwide
by Zacks Equity Research
Eastman Chemical, Cabot and Kronos Worldwide have been highlighted in this Industry Outlook article.
Eastman Chemical (EMN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Diversified Chemical Stocks to Escape Industry Headwinds
by Anindya Barman
Demand softness in specific markets, de-stocking and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. EMN, CBT and KRO are poised to navigate the industry challenges.
Will Eastman Chemical (EMN) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Eastman Chemical (EMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Here's Why You Should Hold Onto Eastman Chemical (EMN) for Now
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from weak demand and inventory de-stocking, it benefits from cost management and pricing actions and innovation.